The product, GSK’s Arexvy, was approved for adults ages 60 and older.
A vaccine to protect infants in their first six months of life — the age group at highest risk of being hospitalized with RSV — is expected to gain FDA approval later this year. Developed by Pfizer, it is designed to be given to pregnant people to generate antibodies that protect both the pregnant person and their newborn. Also up for approval soon is an antibody treatment, to be marketed in the U.S. by Sanofi, that would be given as an injection after birth or near the start of RSV season to protect in the first year of life.
Developed by Pfizer, it is designed to be given to pregnant people to generate antibodies that protect both the pregnant person and their newborn.
Where have we seen this before?
Jesus Christ 😒🤦🏼
To be fair, I would be 100% ok with making this vaccine mandatory for pregnant men and pregnant non-women.